Protein biomarkers can be used to characterize symptom classes, which describe the
metabolic or immunodeficient state of patients during the progression of a specific disease …

The molecular manifestations of host cells responding to SARS-CoV-2 and its evolving
variants of infection are vastly different across the studied models and conditions, imposing …

Since its outbreak in late 2021, the Omicron variant of severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2) has been widely reported to be able to evade neutralizing …

Toxoplasma gondii, a protozoan parasite with the ability to infect various warm-blooded
vertebrates, including humans, is the causative agent of toxoplasmosis. This infection poses …

SARS-CoV-2 remains an acute threat to human health, endangering hospital capacities
worldwide. Previous studies have aimed at informing pathophysiologic understanding and …

Significant progress has been made in preventing severe COVID-19 disease through the
development of vaccines. However, we still lack a validated baseline predictive biologic …

COVID-19 is the most impacting global pandemic of all time, with over 600 million infected
and 6.5 million deaths worldwide, in addition to an unprecedented economic impact …

With the advent of robust and high-throughput mass spectrometric technologies and
bioinformatics tools to analyze large data sets, proteomics has penetrated broadly into basic …

Since the start of 2020, the world has been upended by the pandemic caused by the severe
acute respiratory coronavirus type 2 (SARS‐CoV‐2), the causative agent of coronavirus …

COVID-19 is a heterogeneous disease caused by SARS-CoV-2. Aside from infections of the
lungs, the disease can spread throughout the body and damage many other tissues, leading …